BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20092576)

  • 1. Prostaglandin E receptor EP1 enhances GABA-mediated inhibition of dopaminergic neurons in the substantia nigra pars compacta and regulates dopamine level in the dorsal striatum.
    Tanaka Y; Furuyashiki T; Momiyama T; Namba H; Mizoguchi A; Mitsumori T; Kayahara T; Shichi H; Kimura K; Matsuoka T; Nawa H; Narumiya S
    Eur J Neurosci; 2009 Dec; 30(12):2338-46. PubMed ID: 20092576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.
    Lavoute C; Weiss M; Rostain JC
    Exp Neurol; 2008 Jul; 212(1):63-70. PubMed ID: 18452916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of NMDA and GABAA receptors in the inhibiting effect of 3 MPa nitrogen on striatal dopamine level.
    Lavoute C; Weiss M; Rostain JC
    Brain Res; 2007 Oct; 1176():37-44. PubMed ID: 17900538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential modulation by nicotine of substantia nigra versus ventral tegmental area dopamine neurons.
    Keath JR; Iacoviello MP; Barrett LE; Mansvelder HD; McGehee DS
    J Neurophysiol; 2007 Dec; 98(6):3388-96. PubMed ID: 17942622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABAergic control of substantia nigra dopaminergic neurons.
    Tepper JM; Lee CR
    Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct mechanisms of presynaptic inhibition at GABAergic synapses of the rat substantia nigra pars compacta.
    Giustizieri M; Bernardi G; Mercuri NB; Berretta N
    J Neurophysiol; 2005 Sep; 94(3):1992-2003. PubMed ID: 15944237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine inhibits GABA(A) currents in ventral tegmental area dopamine neurons via activation of presynaptic G-protein coupled inwardly-rectifying potassium channels.
    Michaeli A; Yaka R
    Neuroscience; 2010 Feb; 165(4):1159-69. PubMed ID: 19944748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SK channel function regulates the dopamine phenotype of neurons in the substantia nigra pars compacta.
    Aumann TD; Gantois I; Egan K; Vais A; Tomas D; Drago J; Horne MK
    Exp Neurol; 2008 Oct; 213(2):419-30. PubMed ID: 18680743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited regulation of somatodendritic dopamine release by voltage-sensitive Ca channels contrasted with strong regulation of axonal dopamine release.
    Chen BT; Moran KA; Avshalumov MV; Rice ME
    J Neurochem; 2006 Feb; 96(3):645-55. PubMed ID: 16405515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human GABA A receptors on dopaminergic neurons in the pars compacta of the substantia nigra.
    Petri S; Krampfl K; Dengler R; Bufler J; Weindl A; Arzberger T
    J Comp Neurol; 2002 Oct; 452(4):360-6. PubMed ID: 12355418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity.
    Carrasco E; Casper D; Werner P
    J Neurosci Res; 2007 Nov; 85(14):3109-17. PubMed ID: 17868147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signalling through phospholipase C beta 4 is not essential for midbrain dopaminergic neuron survival.
    Smits SM; van der Nobelen S; Hornman KJ; von Oerthel L; Burbach JP; Smidt MP
    Neuroscience; 2005; 136(1):171-9. PubMed ID: 16198487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of the GABAergic and dopaminergic mesostriatal projections to the lesion of the contralateral dopaminergic mesostriatal pathway in the rat.
    González-Hernández T; Barroso-Chinea P; Rodríguez M
    Mov Disord; 2004 Sep; 19(9):1029-1042. PubMed ID: 15372592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pallidal control of substantia nigra dopaminergic neuron firing pattern and its relation to extracellular neostriatal dopamine levels.
    Lee CR; Abercrombie ED; Tepper JM
    Neuroscience; 2004; 129(2):481-9. PubMed ID: 15501605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
    Zeevalk GD; Manzino L; Sonsalla PK
    Exp Neurol; 2000 Feb; 161(2):638-46. PubMed ID: 10686083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice.
    Mitsumoto Y; Watanabe A; Mori A; Koga N
    Biochem Biophys Res Commun; 1998 Jul; 248(3):660-3. PubMed ID: 9703982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological properties of zebra finch ventral tegmental area and substantia nigra pars compacta neurons.
    Gale SD; Perkel DJ
    J Neurophysiol; 2006 Nov; 96(5):2295-306. PubMed ID: 16870835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABAergic afferents activate both GABAA and GABAB receptors in mouse substantia nigra dopaminergic neurons in vivo.
    Brazhnik E; Shah F; Tepper JM
    J Neurosci; 2008 Oct; 28(41):10386-98. PubMed ID: 18842898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic deficiency in mice with reduced levels of the dual-specificity tyrosine-phosphorylated and regulated kinase 1A, Dyrk1A(+/-).
    Martinez de Lagran M; Bortolozzi A; Millan O; Gispert JD; Gonzalez JR; Arbones ML; Artigas F; Dierssen M
    Genes Brain Behav; 2007 Aug; 6(6):569-78. PubMed ID: 17137466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.